U.S. RESEARCH ROUNDUP-Citigroup, Salesforce, Zscaler

LEMONADE

03/12/2024 07:11

Dec 3 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Citigroup, Salesforce and Zscaler, on
Tuesday. 
    
  HIGHLIGHTS      
    
                 * Citigroup  C.N : KBW raises to outperform from market perform
 
                 * PTC Therapeutics Inc  PTCT.O : RBC raises to outperform from sector perform
 
                 * Salesforce Inc  CRM.N : D.A. Davidson raises target price to $300 from $250
 
                 * State Street Corp  STT.N : KBW raises to outperform from market perform
 
                 * Zscaler Inc  ZS.O : Piper Sandler raises target price to $235 from $215
 
                
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.            
    
                 * Ares Management Corp  ARES.N : CFRA raises target price by $15 to $205
 
                 * Citigroup  C.N : KBW raises target price to $82 from $70
 
                 * Citigroup  C.N : KBW raises to outperform from market perform
 
                 * Fedex Corp  FDX.N : JP Morgan raises target price to $366 from $350
 
                 * GE Vernova Inc  GEV.N : JP Morgan raises target price to $356 from $330
 
                 * Hologic Inc  HOLX.O : Stephens cuts target price to $90 from $95
 
                 * Lemonade Inc  LMND.N : Jefferies raises target price to $20 from $17
 
                 * Ligand Pharmaceuticals Inc  LGND.O : RBC raises target price to $141 from $140
 
                 * PTC Therapeutics Inc  PTCT.O : Jefferies raises target price to $62 from $55
 
                 * PTC Therapeutics Inc  PTCT.O : JP Morgan raises target price to $74 from $62
 
                 * PTC Therapeutics Inc  PTCT.O : Leerink Partners raises target price to $50 from $40
 
                 * PTC Therapeutics Inc  PTCT.O : RBC raises target price to $63 from $39
 
                 * PTC Therapeutics Inc  PTCT.O : RBC raises to outperform from sector perform
 
                 * Revolution Medicines Inc  RVMD.O : JP Morgan raises target price to $71 from $63
 
                 * Salesforce Inc  CRM.N : D.A. Davidson raises target price to $300 from $250
 
                 * State Street Corp  STT.N : KBW raises target price to $120 from $105
 
                 * State Street Corp  STT.N : KBW raises to outperform from market perform
 
                 * Zscaler Inc  ZS.O : Piper Sandler raises target price to $235 from $215
 
                 * Zscaler Inc  ZS.O : Scotiabank raises target price to $205 from $195
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))